Literature DB >> 2876984

Inactivation of the bovine heart mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoyl[3H]inosine is accompanied by modification of tyrosine 345 in a single beta subunit.

D A Bullough, W S Allison.   

Abstract

The inactivation of the bovine heart mitochondrial F1-ATPase by 5'-p-fluorosulfonylbenzoylinosine (FSBI) proceeds with pseudo-first order kinetics. The rate of inactivation increased from pH 7 to 9 revealing a pKa of about 8.2. When a tryptic digest of the enzyme which had been inactivated with 5'-p-fluorosulfonylbenzoyl[3H]inosine ([3H]FSBI) was submitted to reversed phase high pressure liquid chromatography, a single major peak of radioactivity, T1, was resolved. Amino acid sequence analysis of purified peptide fragments derived from T1 showed that the modification of beta-Tyr-345 is responsible for inactivation of the enzyme. Complete inactivation of the enzyme by [3H]FSBI is estimated to proceed with modification of 0.8 mol of beta-Tyr-345/mol of enzyme. Another notable observation is that inosine triphosphatase (ITPase) activity catalyzed by F1 from bovine heart mitochondria is much more sensitive to inactivation by 5'-p-fluorosulfonylbenzoyladenosine (FSBA) than is ATPase activity. Whereas complete inactivation of ATPase activity by FSBA has been shown to proceed with the mutually exclusive modification of Tyr-368 or His-427 in all three copies of the beta subunit (Bullough, D. A., and Allison, W. S. (1986) J. Biol. Chem. 261, 5722-5730), it is shown here that complete inactivation of ITPase activity by FSBA is accompanied by modification of these residues in only one copy of the beta subunit. Inactivation of both the ATPase and ITPase activities of the enzyme by FSBI proceeds with modification of Tyr-345 in a single copy of the beta subunit.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2876984

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Quaternary structure of ATP synthases: symmetry and asymmetry in the F1 moiety.

Authors:  L M Amzel; M A Bianchet; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

Review 2.  Functional sites in F1-ATPases: location and interactions.

Authors:  W S Allison; J M Jault; S Zhuo; S R Paik
Journal:  J Bioenerg Biomembr       Date:  1992-10       Impact factor: 2.945

Review 3.  The ATP synthase (F0-F1) complex in oxidative phosphorylation.

Authors:  J P Issartel; A Dupuis; J Garin; J Lunardi; L Michel; P V Vignais
Journal:  Experientia       Date:  1992-04-15

Review 4.  ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas.

Authors:  Sangjin Hong; Peter L Pedersen
Journal:  Microbiol Mol Biol Rev       Date:  2008-12       Impact factor: 11.056

Review 5.  Regulatory proteins of F1F0-ATPase: role of ATPase inhibitor.

Authors:  T Hashimoto; Y Yoshida; K Tagawa
Journal:  J Bioenerg Biomembr       Date:  1990-02       Impact factor: 2.945

Review 6.  Chemical modification of active sites in relation to the catalytic mechanism of F1.

Authors:  J H Wang
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

Review 7.  The number of functional catalytic sites on F1-ATPases and the effects of quaternary structural asymmetry on their properties.

Authors:  R L Cross
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

Review 8.  ATP synthases--structure of the F1-moiety and its relationship to function and mechanism.

Authors:  X Ysern; L M Amzel; P L Pedersen
Journal:  J Bioenerg Biomembr       Date:  1988-08       Impact factor: 2.945

Review 9.  Molecular genetics of F1-ATPase from Escherichia coli.

Authors:  M Futai; T Noumi; M Maeda
Journal:  J Bioenerg Biomembr       Date:  1988-02       Impact factor: 2.945

10.  Adenine nucleotide binding sites on beef heart F1 ATPase: photoaffinity labeling of beta-subunit Tyr-368 at a noncatalytic site and beta Tyr-345 at a catalytic site.

Authors:  R L Cross; D Cunningham; C G Miller; Z X Xue; J M Zhou; P D Boyer
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.